Evidence map›Paper›PMID 39499795›Full record

SynthesisNutrition reviews2025

APOE ε4 and Dietary Patterns in Relation to Cognitive Function: An Umbrella Review of Systematic Reviews.

Thomas J Urich, Amaryllis A Tsiknia, Nada Ali, Jackson Park, Wendy J Mack, Victoria K Cortessis, Jennifer E Dinalo, Hussein N Yassine

Abstract readSystematic Review
In one paragraph

Synthesis in Nutrition reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thomas J UrichDepartment of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
Amaryllis A TsikniaImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA 90033, United States.
Nada AliDepartment of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
Jackson ParkDepartment of Medicine, University of Southern California, Los Angeles, CA 90033, United States.
Wendy J MackDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, CA 90033, United States.
Victoria K CortessisDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles, CA 90033, United States.
Jennifer E DinaloNorris Medical Library, University of Southern California, Los Angeles, CA 90033, United States.
Hussein N YassineDepartment of Medicine, University of Southern California, Los Angeles, CA 90033, United States.ORCID 0000-0002-2483-649X

Funding

USCADRC Diversity Supplement PachicanoP30AG066530 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HELENA Chang CHUI · 2020 to 2026
$27.8M
The delivery of essential fatty acids to the Brain in Alzheimer's diseaseR01AG054434 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2017 to 2021
$5.4M
Biomarkers of ABCA1 mediated functions in Alzheimers diseaseR01AG055770 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2017 to 2021
$4.2M
Effect of diabetes and AD pathology on brain imaging and cognition in Latino adultsRF1AG078362 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BORZAGE, MATTHEW, BRASKIE, MEREDITH NICOLE · 2022 to 2022
$3.8M
ApoE, ABCA1 and endosomal dysregulation in ADR01AG067063 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2020 to 2024
$3.4M
Brain cPLA2 as a mechanism for neuroinflammation in AD/ADRD with and without APOE4 Diversity SupplementRF1AG076124 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ARVANITAKIS, ZOE, YASSINE, HUSSEIN N · 2022 to 2024
$2.5M
DHA brain delivery by APOE genotypeR21AG056518 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YASSINE, HUSSEIN N · 2018 to 2019
$464k
Alzheimer's Drug Discovery FoundationKenneth and Bette Volk Endowed Chair of Neurology P30AG066530Kenneth and Bette Volk Endowed Chair of Neurology R01AG054434Kenneth and Bette Volk Endowed Chair of Neurology R01AG055770Kenneth and Bette Volk Endowed Chair of Neurology R01AG067063Kenneth and Bette Volk Endowed Chair of Neurology R21AG056518Kenneth and Bette Volk Endowed Chair of Neurology RF1AG076124Kenneth and Bette Volk Endowed Chair of Neurology RF1AG078362NIA NIH HHS GC-201711-2014197NIA NIH HHS P30 AG066530NIA NIH HHS R01 AG054434NIA NIH HHS R01 AG055770NIA NIH HHS R01 AG067063NIA NIH HHS R21 AG056518NIA NIH HHS RF1 AG076124NIA NIH HHS RF1 AG078362Vranos and Tiny Foundations
6 · The paper itself

Abstract

contextCarrying the apolipoprotein ε4 allele (APOE ε4) is the strongest genetic risk factor for late-onset Alzheimer's disease. There is some evidence suggesting that APOE ε4 may modulate the influence of diet on cognitive function.

objectiveThis umbrella review of systematic reviews evaluates the existing literature on the effect of dietary interventions on cognitive and brain-imaging outcomes by APOE status. DATA SOURCES: PubMed, EMBASE, Web of Science, and Scopus were searched using terms appropriate to each area of research, from their respective starting dates of coverage until March 2023. DATA EXTRACTION: Two independent reviewers conducted data extraction and performed a quality appraisal using the Measurement Tool to Assess Systematic Reviews (AMSTAR) 2. DATA ANALYSIS: Six total reviews were included in the final analysis. Four reviews evaluated randomized controlled trials on individuals aged 50-93 years ranging the entire cognitive continuum. One review combined observational studies and clinical trials conducted on both cognitively healthy and cognitively impaired individuals (age range: 50-90), and 1 review included observational studies of both cognitively healthy and cognitively impaired adults (age range: 50-75).

resultsBoth observational studies and clinical trials yielded inconclusive results attributed to both practical limitations associated with longitudinal follow-up and issues of methodological quality. Except for the Mediterranean diet, dietary interventions, such as the ketogenic diet, nutraceuticals, and supplements, were generally not effective in older APOE ε4 carriers. This review considers plausible biological mechanisms that might explain why older and cognitively impaired APOE ε4 carriers were less likely to benefit.

conclusionThis review identifies notable gaps in the literature, such as a shortage of studies conducted in middle-aged and cognitively healthy APOE ε4 carriers assessing the impact of dietary interventions and provides suggestions for novel trial designs.

Indexed as

Apolipoprotein E4CognitionCognitive DysfunctionDietAgedAged, 80 and overAlzheimer DiseaseHumansMiddle AgedRandomized Controlled Trials as TopicSystematic Reviews as TopicApolipoprotein E4child healthdietepidemiologyhealth disparitiesmalnutritionmaternal healthmicronutrientspublic healthsupplementation

Identifiers

PMID39499795
PMCPMC12166175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.